Cidofovir in the Treatment of BK Virus–Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell TransplantationMichaël Philippe, Catherine Rioufol, Sophie Ducastelle-Leprêtre et al.|Transplantation and Cellular Therapy|2015Cited by 79
Immunosuppression medication adherence after allogeneic hematopoietic stem cell transplant: Impact of a specialized clinical pharmacy programFlorent Charra, Florence Ranchon, Michaël Philippe et al.|Journal of Oncology Pharmacy Practice|2021Cited by 10
Tacrolimus Extended Release Formulation Given As An Alternative To Ciclosporine A In Case Of Renal Impairment After Allogeneic HSCT: Results From a Prospective Pilot StudyMarie Y. Detrait, Fiorenza Barraco, Stéphane Morisset et al.|Blood|2013Cited by 0
Flamsa-RIC Sequential Regimen in High Risk CR1 AML Patients: Preliminary Results From a Pilot StudyMarie Y. Detrait, Mauricette Michallet, Mohamad Sobh et al.|Blood|2012Cited by 0
Tacrolimus Extended Release could be an Alternative to the use of Cyclosporine after Allogeneic HSCT in case of Renal Impairment due to Cyclosporine: A Prospective pilot study from two centers in FranceMarie Y. Detrait, Fiorenza Barraco, Stéphane Morisset et al.|Transplantation Research Journal|2017Cited by 0